article thumbnail

Toxicology transformed: Why accuracy now leads the way

Drug Target Review

Our approach, grounded in Good Laboratory Practice (GLP) and honed through thousands of studies, ensures that even the most subtle toxicological indicators are reliably detected. Sompura, Method Development Team Lead at Sannova Analytical, brings over 18 years of experience in the Bioanalytical Laboratory Department.

article thumbnail

A spatial approach to understanding drug dynamics using mass spectrometry imaging

Drug Target Review

Mass spectrometry imaging (MSI) enables the direct detection and quantitation of active pharmaceutical ingredients (APIs) and metabolites within tissue sections, making it widely regarded as a promising technique in the field of pharmacology and toxicology.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Key Trends Drug Developers Need to Know to Succeed

PPD

As the pharmaceutical industry continues to evolve, drug developers encounter new challenges and opportunities in their pursuit of innovation. Patient recruitment and clinical laboratory and diagnostic services are the top drug development activities likely to be outsourced, similar to previous reports.

article thumbnail

Solving the disconnect between lab and data scientists: part 1

Drug Target Review

In the rapidly evolving landscape of life sciences, the communication gap between laboratory scientists and data scientists remains a significant challenge. I began developing my own scripts to streamline processes, which led me into scientific informatics, where I worked with pharmaceutical companies on cheminformatics.

article thumbnail

Case Study: Two Examples of Successful Automation Integration at Altasciences for Pharmacokinetic Studies

Alta Sciences

For biotechnology and pharmaceutical companies, automation can decrease their drug-to-market development time and remain financially competitive in an evolving market. My experience as an optimization scientist has shown how automation can be a valuable tool to support drug development for sponsors of all sizes.

article thumbnail

Bio-Techne Joins Forces with USP to Speed Up Development of mAbs and Gene Therapies

The Pharma Data

In this context, the USP’s mAb reference standards offer pharmaceutical manufacturers a critical benchmark. With Bio-Techne’s global distribution network and integrated analytical platforms like the MauriceFlex™, more laboratories can now seamlessly adopt these standards into their workflows. “We

article thumbnail

Phase 3 Trial of Ifinatamab Deruxtecan Begins in Advanced Prostate Cancer

The Pharma Data

Dr. Marjorie Green, Senior Vice President and Head of Oncology Global Clinical Development at Merck Research Laboratories, emphasized the significance of this new trial within the broader scope of the ADC’s development.